title: Mining the ACCENT database: a review and update.
abstract: The database of the Adjuvant Colon Cancer End Points (ACCENT) Group was assembled to address questions in early stage colon cancer that could be best answered by information pooled across many similar trials. Today, the ACCENT database contains individual patient-level data from over 33,000 patients enrolled onto 25 adjuvant colon cancer trials conducted between 1977 and 2008. Since its flagship analysis of 3-year disease-free survival as a surrogate endpoint for 5-year overall survival in 2005, the ACCENT group has produced many noteworthy scientific findings addressing a variety of clinical questions, which we describe here. Additionally, we provide an overview of the history, collaboration, construction, principles, and future of the ACCENT database, as it has set a precedent for multi-trial database creation in other types of cancer.
authors.affiliation: Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. renfro.lindsay@mayo.edu.
authors.forename: Lindsay A
authors.initials: LA
authors.lastname: Renfro
authors.affiliation: Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
authors.forename: Qian
authors.initials: Q
authors.lastname: Shi
authors.affiliation: Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Sargent
keywords: Adjuvant Colon Cancer End Points (ACCENT) Group; colon cancer; database
references.citation: J Clin Oncol. 2012 Jul 1;30(19):2334-9
references.pmid: 22614981
references.citation: J Clin Oncol. 2008 May 10;26(14):2336-41
references.pmid: 18467725
references.citation: J Natl Cancer Inst. 2011 Oct 19;103(20):1498-506
references.pmid: 21997132
references.citation: J Clin Oncol. 2007 Oct 10;25(29):4569-74
references.pmid: 17876008
references.citation: N Engl J Med. 2001 Oct 11;345(15):1091-7
references.pmid: 11596588
references.citation: J Clin Oncol. 2004 May 15;22(10):1797-806
references.pmid: 15067028
references.citation: J Clin Oncol. 1999 May;17(5):1356-63
references.pmid: 10334519
references.citation: J Clin Oncol. 2005 Dec 1;23(34):8664-70
references.pmid: 16260700
references.citation: N Engl J Med. 1990 Feb 8;322(6):352-8
references.pmid: 2300087
references.citation: Cancer. 2013 Apr 15;119(8):1528-36
references.pmid: 23310947
references.citation: J Natl Cancer Inst. 2012 Feb 8;104(3):211-27
references.pmid: 22266473
references.citation: Eur J Cancer. 2011 May;47(7):990-6
references.pmid: 21257306
references.citation: Lancet. 1995 Apr 15;345(8955):939-44
references.pmid: 7715291
references.citation: J Clin Oncol. 2009 Feb 20;27(6):872-7
references.pmid: 19124803
references.citation: J Clin Oncol. 2010 Jan 20;28(3):460-5
references.pmid: 20008641
references.citation: Biometrics. 2012 Mar;68(1):258-67
references.pmid: 21838811
references.citation: Br J Cancer. 2013 Mar 5;108(4):784-90
references.pmid: 23385733
references.citation: Stat Med. 2012 Apr 13;31(8):743-61
references.pmid: 22161275